Stem cell infusion trial offers hope for critically ill ARDS patients
NCT ID NCT03042143
Summary
This trial is testing whether a single infusion of donor stem cells can help treat Acute Respiratory Distress Syndrome (ARDS), a life-threatening lung condition often seen in severe COVID-19 and other critical illnesses. The study first checked if the treatment was safe at different doses. It is now comparing the highest safe dose against a placebo in about 120 critically ill patients on ventilators to see if it improves lung function and recovery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Belfast Health and Social Care Trust, Royal Hospitals
Belfast, Northern Ireland, BT12 6BA, United Kingdom
Conditions
Explore the condition pages connected to this study.